CADL
Price
$6.04
Change
+$0.49 (+8.83%)
Updated
Jun 6 closing price
Capitalization
278.07M
87 days until earnings call
VSTM
Price
$6.42
Change
+$0.24 (+3.88%)
Updated
Jun 6 closing price
Capitalization
339.59M
Interact to see
Advertisement

CADL vs VSTM

Header iconCADL vs VSTM Comparison
Open Charts CADL vs VSTMBanner chart's image
Candel Therapeutics
Price$6.04
Change+$0.49 (+8.83%)
Volume$1.14M
Capitalization278.07M
Verastem
Price$6.42
Change+$0.24 (+3.88%)
Volume$1.56M
Capitalization339.59M
CADL vs VSTM Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. VSTM commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CADL: $5.94 vs. VSTM: $7.61)
Brand notoriety: CADL and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 229% vs. VSTM: 146%
Market capitalization -- CADL: $278.07M vs. VSTM: $339.59M
CADL [@Biotechnology] is valued at $278.07M. VSTM’s [@Biotechnology] market capitalization is $339.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 4 bearish.
  • VSTM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CADL and VSTM are a good buy in the short-term.

Price Growth

CADL (@Biotechnology) experienced а +8.59% price change this week, while VSTM (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($340M) has a higher market cap than CADL($278M). VSTM YTD gains are higher at: 47.195 vs. CADL (-31.567). CADL has higher annual earnings (EBITDA): -52.1M vs. VSTM (-125.86M). CADL has more cash in the bank: 103M vs. VSTM (88.8M). CADL has less debt than VSTM: CADL (13.5M) vs VSTM (42.3M). VSTM has higher revenues than CADL: VSTM (10M) vs CADL (0).
CADLVSTMCADL / VSTM
Capitalization278M340M82%
EBITDA-52.1M-125.86M41%
Gain YTD-31.56747.195-67%
P/E RatioN/AN/A-
Revenue010M-
Total Cash103M88.8M116%
Total Debt13.5M42.3M32%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLVSTM
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
80%
Momentum
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 12 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
86%
Aroon
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RPTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+6.07%
RPTX - CADL
40%
Loosely correlated
+1.84%
INKT - CADL
34%
Loosely correlated
-5.49%
INO - CADL
33%
Loosely correlated
N/A
VSTM - CADL
33%
Poorly correlated
-10.68%
CCCC - CADL
32%
Poorly correlated
-3.08%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-10.68%
GNLX - VSTM
48%
Loosely correlated
-3.54%
SNSE - VSTM
46%
Loosely correlated
-4.53%
CADL - VSTM
34%
Loosely correlated
+6.07%
KRON - VSTM
33%
Poorly correlated
-2.46%
BCAB - VSTM
31%
Poorly correlated
+2.18%
More